IP Library Patent Application 11325505
Patent Application
App. No. 11/325,505

Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/325,505
Abstract

The present invention further relates to utilizing the above devices and methods for assaying cellular dynamics and phenotypes to create subject primary cell profiles for patients. Additionally, the present invention relates to methods of correlating primary cell profiles with a therapeutic regimen. Finally, the invention relates to methods for screening test compounds for biological activities by measuring their effect on primary cell profiles.

Claims (10)

1 . A method for creating a primary cell profile, the method comprising in vitro monitoring of primary cells from a test patient wherein said monitoring comprises studying primary cell phenotypes and dynamics selected from the group consisting of cell morphology, molecular marker expression pattern, selective activation, rolling and adhesion properties, transmigration ability, and chemotactic properties.

2 . The method of claim 1 further comprising creating a database of primary cell profiles wherein said data base comprises a primary cell profile for at least one healthy patient and for at least one diseased patient.

3 . A method of predicting a therapeutic outcome for a test patient having a disease, said method comprising

a) generating a primary cell profile for the test patient by the method of claim 1;

b) comparing the primary cell profile of the test patient with the primary cell profile of a profiled patient having the same disease and having received a therapy

c) determining the similarities of the primary cell profiles regarding cell phenotypes and dynamics selected from the group consisting of cell morphology, molecular marker expression pattern, selective activation, rolling and adhesion properties, transmigration ability, and chemotactic properties

d) determining the therapeutic outcome of the profiled patient; and

e) correlating the therapeutic outcome of the profiled patient to predict the therapeutic outcome of the test patient based on the similarities of the primary cell profiles.

4 . The method of claim 1 wherein the cell profile is determined using primary leukocytes.

5 . The method of claim 1 wherein the cell profile is determined using monocytes.

Assignments (3)
ENTITY CONVERSION Recorded Sep 17, 2025
From: SURFACE LOGIX, INC.
To: SURFACE LOGIX LLC
Reel/Frame 072915/0828 →
SECURITY AGREEMENT Recorded Nov 29, 2010
From: SURFACE LOGIX, INC.
To: SILICON VALLEY BANK
Reel/Frame 025406/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2006
From: KIRK, GREGORY L.; OSTUNI, EMANUELE; KIM, ENOCH; SCHUELLER, OLIVIER; SWEETNAM, PAUL
To: SURFACE LOGIX, INC.
Reel/Frame 018467/0800 →